Two Sigma Advisers’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
Two Sigma Advisers's NUVB Position: Q1 2026 in Review
Two Sigma Advisers sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 393,100 shares — an estimated $3.52M sold.
Two Sigma Advisers first reported a position in NUVB in Q1 2022 and held it in 16 quarters. The position peaked at $3.71M in Q1 2024. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Two Sigma Advisers reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 393,100 Nuvation Bio shares in Q1 2026, an estimated $3.52M.
- Two Sigma Advisers first reported a position in Nuvation Bio in Q1 2022 and held it in 16 quarters.
- Two Sigma Advisers's Nuvation Bio position peaked at $3.71M in Q1 2024.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.